Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report.

Abstract

Classic Kaposi's sarcoma (KS) is a disease with low mortality but high morbidity. The optimum treatment of KS depends upon several factors, including location of lesions, disease progression, severity of symptoms and patient preference. We report the long-term response to the use of intralesional doxorubicin to successfully treat a large cutaneous lesion of KS on a patient refractory to traditional treatments.

• Authors: Yasir Azim Mirza, Davide Altamura, Torkan Hirbod, Roberto Verdolini
• Journal: Case reports in dermatology (Case Rep Dermatol) 2015 Jan-Apr Vol. 7 Issue 1 Pg. 17-9 ISSN: 1662-6567 [Print] Switzerland
• PMID: 25848347 (Publication Type: Case Reports)